| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Muscle, Smooth, Vascular | 15 | 2000 | 59 |
Why?
|
3',5'-Cyclic-AMP Phosphodiesterases | 7 | 2001 | 8 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 1 | 8 | 2001 | 9 |
Why?
|
Phosphoric Diester Hydrolases | 7 | 2001 | 29 |
Why?
|
Myocytes, Smooth Muscle | 7 | 2004 | 35 |
Why?
|
Angiotensin II | 14 | 2001 | 31 |
Why?
|
Myocytes, Cardiac | 9 | 2005 | 40 |
Why?
|
Cyclic GMP | 8 | 2001 | 30 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 15 | 2001 | 10 |
Why?
|
Cyclic AMP Response Element Modulator | 4 | 2005 | 7 |
Why?
|
Myocardium | 7 | 2001 | 119 |
Why?
|
Signal Transduction | 25 | 2001 | 313 |
Why?
|
Calmodulin | 3 | 2005 | 34 |
Why?
|
Apoptosis | 12 | 2000 | 265 |
Why?
|
Mitogen-Activated Protein Kinases | 15 | 2000 | 68 |
Why?
|
Second Messenger Systems | 2 | 2009 | 19 |
Why?
|
Nitric Oxide | 5 | 2001 | 85 |
Why?
|
Cells, Cultured | 31 | 2001 | 447 |
Why?
|
Animals | 64 | 2000 | 1031 |
Why?
|
Cell Cycle Proteins | 9 | 2003 | 71 |
Why?
|
Rats | 25 | 2000 | 530 |
Why?
|
Calcium | 6 | 2002 | 208 |
Why?
|
Phosphodiesterase Inhibitors | 3 | 2001 | 18 |
Why?
|
Feedback, Physiological | 4 | 2003 | 26 |
Why?
|
Cell Proliferation | 5 | 2004 | 227 |
Why?
|
Enzyme Activation | 24 | 2000 | 177 |
Why?
|
Phosphoproteins | 10 | 2002 | 86 |
Why?
|
Cardiomegaly | 3 | 2006 | 36 |
Why?
|
NF-kappa B | 8 | 2002 | 114 |
Why?
|
Vinca Alkaloids | 2 | 2001 | 3 |
Why?
|
Reactive Oxygen Species | 9 | 2000 | 112 |
Why?
|
Drug Tolerance | 2 | 2001 | 26 |
Why?
|
Cell Movement | 5 | 2005 | 163 |
Why?
|
Tumor Necrosis Factor-alpha | 10 | 2001 | 210 |
Why?
|
Protein Phosphatase 2 | 2 | 2003 | 15 |
Why?
|
Mice | 29 | 2001 | 623 |
Why?
|
GTPase-Activating Proteins | 6 | 2003 | 13 |
Why?
|
Aorta | 7 | 2001 | 69 |
Why?
|
TCF Transcription Factors | 1 | 2010 | 10 |
Why?
|
Endothelium, Vascular | 9 | 2001 | 139 |
Why?
|
Lysosomes | 1 | 2010 | 38 |
Why?
|
Gene Expression Regulation | 8 | 2002 | 277 |
Why?
|
Collagen Type I | 1 | 2010 | 32 |
Why?
|
Cardiovascular Agents | 1 | 2010 | 18 |
Why?
|
Nephroblastoma Overexpressed Protein | 1 | 2010 | 2 |
Why?
|
Rats, Sprague-Dawley | 11 | 2000 | 257 |
Why?
|
3',5'-Cyclic-GMP Phosphodiesterases | 3 | 2001 | 2 |
Why?
|
Heart | 4 | 2004 | 88 |
Why?
|
I-kappa B Kinase | 1 | 2010 | 26 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 3 | 6 | 2003 | 6 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 10 | 2001 | 36 |
Why?
|
Anti-Inflammatory Agents | 2 | 2006 | 80 |
Why?
|
Endothelial Cells | 9 | 2003 | 80 |
Why?
|
Receptors, Notch | 1 | 2010 | 30 |
Why?
|
beta Catenin | 1 | 2010 | 34 |
Why?
|
Phosphorylation | 20 | 2001 | 224 |
Why?
|
Cardiovascular Diseases | 2 | 2007 | 127 |
Why?
|
Nitric Oxide Donors | 3 | 2001 | 11 |
Why?
|
Pneumonia | 1 | 2010 | 85 |
Why?
|
Gene Expression Regulation, Enzymologic | 3 | 2004 | 104 |
Why?
|
Cyclophilin A | 4 | 2000 | 11 |
Why?
|
Calcium Signaling | 1 | 2009 | 52 |
Why?
|
Enzyme Inhibitors | 8 | 2000 | 216 |
Why?
|
Nitroglycerin | 3 | 2001 | 10 |
Why?
|
Cyclic AMP | 4 | 2001 | 89 |
Why?
|
Nitrates | 2 | 2002 | 27 |
Why?
|
Heart Failure | 3 | 2005 | 106 |
Why?
|
Spermatozoa | 2 | 2001 | 25 |
Why?
|
Phospholipase C gamma | 6 | 2003 | 17 |
Why?
|
Inflammation | 6 | 2001 | 208 |
Why?
|
Humans | 35 | 2001 | 1856 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 4 | 2003 | 62 |
Why?
|
Ribosomal Protein S6 Kinases, 90-kDa | 4 | 2003 | 6 |
Why?
|
MAP Kinase Signaling System | 6 | 2001 | 56 |
Why?
|
Epidermal Growth Factor | 6 | 2003 | 51 |
Why?
|
Haemophilus influenzae | 3 | 2007 | 39 |
Why?
|
Transcription, Genetic | 7 | 2003 | 253 |
Why?
|
Arterioles | 1 | 2002 | 14 |
Why?
|
Protein-Serine-Threonine Kinases | 4 | 2003 | 105 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 11 | 2000 | 37 |
Why?
|
Alternative Splicing | 2 | 2001 | 51 |
Why?
|
Testis | 2 | 2001 | 54 |
Why?
|
Arteriosclerosis | 1 | 2001 | 54 |
Why?
|
MAP Kinase Kinase 5 | 4 | 2001 | 3 |
Why?
|
src-Family Kinases | 6 | 2001 | 30 |
Why?
|
Cyclic GMP-Dependent Protein Kinases | 3 | 2003 | 12 |
Why?
|
Oxidative Stress | 4 | 2000 | 119 |
Why?
|
Mice, Inbred C57BL | 7 | 2001 | 318 |
Why?
|
Gene Expression | 3 | 2001 | 291 |
Why?
|
Myocardial Ischemia | 3 | 2001 | 62 |
Why?
|
Protein-Tyrosine Kinases | 4 | 2001 | 77 |
Why?
|
Proto-Oncogene Proteins | 5 | 2001 | 113 |
Why?
|
RNA, Messenger | 7 | 2001 | 394 |
Why?
|
Heart Ventricles | 3 | 2005 | 86 |
Why?
|
RNA Interference | 5 | 2004 | 75 |
Why?
|
Mice, Transgenic | 7 | 2004 | 209 |
Why?
|
Isoproterenol | 2 | 2005 | 47 |
Why?
|
Isoenzymes | 5 | 2001 | 144 |
Why?
|
Transcription Factor RelA | 2 | 2007 | 36 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 5 | 2001 | 26 |
Why?
|
Cysteine Endopeptidases | 2 | 2007 | 41 |
Why?
|
Haemophilus Infections | 2 | 2007 | 30 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 4 | 2001 | 48 |
Why?
|
Adaptor Proteins, Signal Transducing | 6 | 2002 | 54 |
Why?
|
Tumor Suppressor Proteins | 2 | 2007 | 51 |
Why?
|
Male | 15 | 2000 | 1553 |
Why?
|
Diabetes Mellitus, Experimental | 2 | 2006 | 36 |
Why?
|
Luciferases | 3 | 2003 | 70 |
Why?
|
Transfection | 11 | 2000 | 237 |
Why?
|
Neovascularization, Physiologic | 2 | 2005 | 68 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2002 | 41 |
Why?
|
Cell Line | 11 | 2002 | 375 |
Why?
|
Blotting, Western | 7 | 2001 | 275 |
Why?
|
Transcription Factors | 4 | 2002 | 201 |
Why?
|
Receptor Protein-Tyrosine Kinases | 3 | 2003 | 40 |
Why?
|
Vasodilation | 2 | 2002 | 30 |
Why?
|
Transforming Growth Factor beta | 2 | 2007 | 99 |
Why?
|
Protein Kinase C | 2 | 2005 | 93 |
Why?
|
Mice, Knockout | 7 | 2008 | 265 |
Why?
|
Myocardial Infarction | 3 | 2006 | 129 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 7 | 2001 | 51 |
Why?
|
Blood Pressure | 2 | 2005 | 205 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 5 | 2 | 2001 | 2 |
Why?
|
Renin-Angiotensin System | 2 | 2006 | 15 |
Why?
|
Caspases | 4 | 2003 | 58 |
Why?
|
RNA, Small Interfering | 6 | 2005 | 116 |
Why?
|
NADPH Oxidase | 2 | 2000 | 21 |
Why?
|
Chemotaxis | 2 | 2005 | 20 |
Why?
|
Protein Tyrosine Phosphatases | 2 | 2002 | 27 |
Why?
|
Cell Surface Extensions | 2 | 2008 | 7 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2005 | 94 |
Why?
|
Reperfusion Injury | 2 | 2001 | 22 |
Why?
|
Oncogene Proteins | 2 | 2001 | 26 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 3 | 2004 | 32 |
Why?
|
Mucin 5AC | 2 | 2007 | 2 |
Why?
|
Tyrosine | 6 | 2002 | 71 |
Why?
|
Protein Structure, Tertiary | 8 | 2001 | 163 |
Why?
|
Cattle | 7 | 2002 | 176 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2011 | 6 |
Why?
|
Up-Regulation | 2 | 2001 | 183 |
Why?
|
Cyclic Nucleotide-Gated Cation Channels | 1 | 2010 | 5 |
Why?
|
Tissue Culture Techniques | 1 | 2010 | 10 |
Why?
|
Proto-Oncogene Proteins c-bcr | 2 | 2001 | 5 |
Why?
|
Pulmonary Artery | 2 | 2004 | 58 |
Why?
|
Phenotype | 2 | 2010 | 303 |
Why?
|
Apolipoproteins E | 1 | 2011 | 26 |
Why?
|
Adenylate Cyclase | 1 | 2010 | 24 |
Why?
|
Cell Adhesion | 2 | 2002 | 113 |
Why?
|
Bicarbonates | 1 | 2010 | 40 |
Why?
|
Molecular Targeted Therapy | 1 | 2010 | 4 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2010 | 14 |
Why?
|
Nitric Oxide Synthase Type III | 2 | 2007 | 31 |
Why?
|
Cysteine-Rich Protein 61 | 1 | 2010 | 3 |
Why?
|
Protein Binding | 7 | 2002 | 256 |
Why?
|
Translational Medical Research | 1 | 2010 | 20 |
Why?
|
Femur | 1 | 2010 | 37 |
Why?
|
Oxidation-Reduction | 4 | 2001 | 124 |
Why?
|
Streptococcus pneumoniae | 2 | 2007 | 38 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2010 | 26 |
Why?
|
Hyperplasia | 1 | 2010 | 55 |
Why?
|
Monocytes | 2 | 2002 | 124 |
Why?
|
Nitric Oxide Synthase Type II | 2 | 2006 | 39 |
Why?
|
Dendritic Spines | 1 | 2010 | 12 |
Why?
|
Bone Density | 1 | 2010 | 62 |
Why?
|
Bone Remodeling | 1 | 2010 | 33 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2010 | 31 |
Why?
|
Aortic Aneurysm | 1 | 2009 | 16 |
Why?
|
Enzyme Induction | 3 | 2001 | 64 |
Why?
|
Inflammation Mediators | 3 | 2002 | 56 |
Why?
|
Cell Survival | 3 | 2003 | 229 |
Why?
|
Cardiotonic Agents | 1 | 2009 | 21 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 3 | 2002 | 27 |
Why?
|
Pulmonary Veins | 1 | 2009 | 22 |
Why?
|
Hydrogen Peroxide | 5 | 2002 | 75 |
Why?
|
Type C Phospholipases | 3 | 2002 | 34 |
Why?
|
Learning | 1 | 2010 | 66 |
Why?
|
Cell Cycle | 1 | 2010 | 121 |
Why?
|
Small Ubiquitin-Related Modifier Proteins | 1 | 2008 | 6 |
Why?
|
Ventricular Dysfunction | 1 | 2008 | 8 |
Why?
|
NFATC Transcription Factors | 1 | 2008 | 15 |
Why?
|
SUMO-1 Protein | 1 | 2008 | 12 |
Why?
|
Potassium Channels, Voltage-Gated | 1 | 2008 | 17 |
Why?
|
Protein Kinase Inhibitors | 2 | 2004 | 59 |
Why?
|
Blood Circulation | 1 | 2008 | 26 |
Why?
|
Models, Biological | 5 | 2002 | 410 |
Why?
|
Pneumonia, Pneumococcal | 1 | 2007 | 11 |
Why?
|
Dexamethasone | 1 | 2008 | 109 |
Why?
|
Thrombosis | 1 | 2010 | 105 |
Why?
|
Osteoclasts | 1 | 2010 | 48 |
Why?
|
Superoxides | 1 | 2007 | 36 |
Why?
|
Cell Membrane Permeability | 1 | 2007 | 57 |
Why?
|
Mucins | 1 | 2007 | 26 |
Why?
|
PPAR gamma | 1 | 2008 | 38 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2001 | 431 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2008 | 25 |
Why?
|
Glucocorticoids | 1 | 2008 | 107 |
Why?
|
Histone Deacetylases | 1 | 2008 | 30 |
Why?
|
Aorta, Thoracic | 1 | 2007 | 54 |
Why?
|
PPAR delta | 1 | 2006 | 3 |
Why?
|
Pulmonary Alveoli | 1 | 2009 | 80 |
Why?
|
Cloning, Molecular | 3 | 2001 | 183 |
Why?
|
Kallikreins | 1 | 2006 | 6 |
Why?
|
Otitis Media | 1 | 2008 | 34 |
Why?
|
Superoxide Dismutase | 2 | 2002 | 46 |
Why?
|
Connexin 43 | 2 | 2003 | 14 |
Why?
|
Heme Oxygenase-1 | 1 | 2006 | 28 |
Why?
|
Doxorubicin | 1 | 2007 | 60 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2006 | 24 |
Why?
|
Acetophenones | 1 | 2005 | 5 |
Why?
|
Platelet-Derived Growth Factor | 2 | 2001 | 37 |
Why?
|
Diabetic Angiopathies | 1 | 2006 | 24 |
Why?
|
Vitamins | 1 | 2006 | 30 |
Why?
|
Vasodilator Agents | 2 | 2001 | 56 |
Why?
|
Blood Flow Velocity | 2 | 2001 | 72 |
Why?
|
Ascorbic Acid | 1 | 2006 | 37 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2005 | 5 |
Why?
|
Troponin I | 1 | 2005 | 6 |
Why?
|
Vitamin E | 1 | 2006 | 38 |
Why?
|
Trifluoperazine | 1 | 2005 | 7 |
Why?
|
Genomics | 1 | 2005 | 36 |
Why?
|
Conserved Sequence | 1 | 2005 | 73 |
Why?
|
Cytoplasm | 1 | 2006 | 108 |
Why?
|
Free Radical Scavengers | 2 | 2000 | 26 |
Why?
|
Time Factors | 7 | 2001 | 896 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2006 | 82 |
Why?
|
MAP Kinase Kinase Kinases | 4 | 2002 | 28 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2004 | 17 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2006 | 35 |
Why?
|
HeLa Cells | 4 | 2003 | 107 |
Why?
|
Animals, Newborn | 3 | 2009 | 175 |
Why?
|
Amino Acid Sequence | 3 | 2001 | 319 |
Why?
|
S-Nitroso-N-Acetylpenicillamine | 1 | 2003 | 5 |
Why?
|
Oxadiazoles | 1 | 2003 | 6 |
Why?
|
Quinoxalines | 1 | 2003 | 9 |
Why?
|
Guanylate Cyclase | 1 | 2003 | 10 |
Why?
|
Natriuretic Peptide, C-Type | 1 | 2003 | 5 |
Why?
|
Recombinant Proteins | 4 | 2000 | 290 |
Why?
|
Thionucleotides | 1 | 2003 | 15 |
Why?
|
Hemorheology | 1 | 2003 | 12 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2004 | 64 |
Why?
|
Immunoprecipitation | 3 | 2005 | 57 |
Why?
|
Receptors, Angiotensin | 1 | 2003 | 10 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2004 | 29 |
Why?
|
Heart Rate | 1 | 2005 | 138 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 49 |
Why?
|
Cell Division | 4 | 2000 | 273 |
Why?
|
Case-Control Studies | 1 | 2005 | 283 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2003 | 30 |
Why?
|
Losartan | 1 | 2002 | 4 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2002 | 7 |
Why?
|
Precipitin Tests | 4 | 2001 | 81 |
Why?
|
Metalloporphyrins | 1 | 2002 | 8 |
Why?
|
Chemokine CCL2 | 1 | 2003 | 57 |
Why?
|
Gap Junctions | 1 | 2003 | 15 |
Why?
|
Cell Nucleus | 1 | 2006 | 169 |
Why?
|
Promoter Regions, Genetic | 1 | 2005 | 188 |
Why?
|
Molecular Sequence Data | 3 | 2001 | 404 |
Why?
|
Echocardiography | 3 | 2004 | 93 |
Why?
|
Brain | 1 | 2010 | 305 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2001 | 21 |
Why?
|
Atrial Natriuretic Factor | 1 | 2001 | 15 |
Why?
|
Seminiferous Epithelium | 1 | 2001 | 2 |
Why?
|
Spermatids | 1 | 2001 | 5 |
Why?
|
Plasmids | 4 | 2002 | 122 |
Why?
|
Tunica Intima | 3 | 2001 | 31 |
Why?
|
Microscopy, Fluorescence | 3 | 2003 | 137 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2002 | 64 |
Why?
|
Meiosis | 1 | 2001 | 15 |
Why?
|
Spermatogenesis | 1 | 2001 | 14 |
Why?
|
Adenosine | 1 | 2001 | 57 |
Why?
|
Sequence Analysis | 1 | 2001 | 23 |
Why?
|
Disease Models, Animal | 3 | 2008 | 349 |
Why?
|
Fluorescent Antibody Technique | 1 | 2001 | 164 |
Why?
|
Cytosol | 1 | 2001 | 79 |
Why?
|
DNA-Binding Proteins | 2 | 2002 | 204 |
Why?
|
In Situ Hybridization | 1 | 2001 | 135 |
Why?
|
Nerve Growth Factors | 1 | 2001 | 43 |
Why?
|
Lung | 1 | 2007 | 232 |
Why?
|
Sequence Alignment | 1 | 2001 | 114 |
Why?
|
RNA Splicing | 1 | 2001 | 42 |
Why?
|
Stress, Mechanical | 3 | 2002 | 93 |
Why?
|
Immunoblotting | 3 | 2003 | 119 |
Why?
|
Neurons | 2 | 2001 | 195 |
Why?
|
Streptozocin | 2 | 2008 | 18 |
Why?
|
MAP Kinase Kinase 3 | 2 | 2007 | 3 |
Why?
|
Streptolysins | 2 | 2007 | 10 |
Why?
|
CHO Cells | 3 | 2001 | 65 |
Why?
|
Acetylation | 2 | 2007 | 46 |
Why?
|
Oxidants | 2 | 2008 | 47 |
Why?
|
DNA | 3 | 2001 | 262 |
Why?
|
Cricetinae | 3 | 2001 | 130 |
Why?
|
Mice, Inbred Strains | 2 | 2007 | 118 |
Why?
|
Cell Line, Tumor | 2 | 2008 | 208 |
Why?
|
Rheology | 2 | 2002 | 28 |
Why?
|
In Situ Nick-End Labeling | 2 | 2003 | 65 |
Why?
|
Rabbits | 2 | 2006 | 252 |
Why?
|
Potassium Chloride | 2 | 2001 | 42 |
Why?
|
Recombinant Fusion Proteins | 2 | 2004 | 189 |
Why?
|
Nitroprusside | 2 | 2000 | 24 |
Why?
|
Caspase 3 | 2 | 2003 | 56 |
Why?
|
Bacterial Proteins | 2 | 2007 | 99 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2003 | 22 |
Why?
|
Carotid Arteries | 2 | 2001 | 51 |
Why?
|
MAP Kinase Kinase 1 | 2 | 2003 | 12 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2003 | 156 |
Why?
|
MAP Kinase Kinase Kinase 3 | 2 | 2002 | 4 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 2 | 2002 | 10 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2003 | 58 |
Why?
|
Serine | 2 | 2003 | 62 |
Why?
|
Gene Deletion | 2 | 2002 | 121 |
Why?
|
Binding Sites | 2 | 2004 | 213 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2002 | 73 |
Why?
|
Fumarates | 1 | 2011 | 15 |
Why?
|
Renin | 1 | 2011 | 26 |
Why?
|
Amides | 1 | 2011 | 28 |
Why?
|
X-Ray Microtomography | 1 | 2010 | 14 |
Why?
|
Calcification, Physiologic | 1 | 2010 | 23 |
Why?
|
Cell Membrane Structures | 1 | 2010 | 6 |
Why?
|
Protein Stability | 1 | 2010 | 11 |
Why?
|
Phorbol 12,13-Dibutyrate | 1 | 2010 | 11 |
Why?
|
Transcriptional Activation | 2 | 2002 | 99 |
Why?
|
Mutant Proteins | 1 | 2010 | 20 |
Why?
|
Alkaline Phosphatase | 1 | 2010 | 59 |
Why?
|
Receptor Activator of Nuclear Factor-kappa B | 1 | 2010 | 22 |
Why?
|
Cell Communication | 1 | 2011 | 72 |
Why?
|
Environment | 1 | 2010 | 43 |
Why?
|
Bone Marrow Cells | 1 | 2011 | 92 |
Why?
|
Base Sequence | 2 | 2004 | 371 |
Why?
|
Cell Size | 1 | 2010 | 68 |
Why?
|
Pulmonary Circulation | 1 | 2009 | 42 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2008 | 4 |
Why?
|
Phosphoserine | 1 | 2008 | 14 |
Why?
|
Dual Specificity Phosphatase 1 | 1 | 2008 | 3 |
Why?
|
Matrix Metalloproteinase 14 | 1 | 2008 | 12 |
Why?
|
Actins | 1 | 2010 | 112 |
Why?
|
Blood-Brain Barrier | 1 | 2010 | 63 |
Why?
|
Cerebrovascular Circulation | 1 | 2010 | 62 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2008 | 28 |
Why?
|
Vasculitis | 1 | 2008 | 18 |
Why?
|
Bone Resorption | 1 | 2010 | 49 |
Why?
|
Bone Marrow Transplantation | 1 | 2011 | 90 |
Why?
|
Hippocampus | 1 | 2010 | 83 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2008 | 6 |
Why?
|
Osteoblasts | 1 | 2010 | 39 |
Why?
|
Culture Media, Conditioned | 1 | 2008 | 45 |
Why?
|
Toll-Like Receptor 2 | 1 | 2008 | 9 |
Why?
|
Shear Strength | 1 | 2008 | 13 |
Why?
|
Toll-Like Receptor 4 | 1 | 2008 | 14 |
Why?
|
Ubiquitination | 1 | 2008 | 10 |
Why?
|
Glycosylation End Products, Advanced | 1 | 2008 | 4 |
Why?
|
Protein Inhibitors of Activated STAT | 1 | 2008 | 5 |
Why?
|
Calcineurin | 1 | 2008 | 12 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2008 | 17 |
Why?
|
Neuropsychological Tests | 1 | 2010 | 113 |
Why?
|
Adaptation, Psychological | 1 | 2010 | 110 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 2 | 1 | 2007 | 1 |
Why?
|
Serpin E2 | 1 | 2007 | 3 |
Why?
|
Phenylephrine | 1 | 2007 | 25 |
Why?
|
p21-Activated Kinases | 1 | 2007 | 3 |
Why?
|
Serpins | 1 | 2007 | 14 |
Why?
|
Cell Extracts | 1 | 2007 | 7 |
Why?
|
Vasoconstrictor Agents | 1 | 2007 | 26 |
Why?
|
Hyperglycemia | 1 | 2008 | 31 |
Why?
|
Point Mutation | 1 | 2008 | 122 |
Why?
|
Acetylcholine | 1 | 2007 | 49 |
Why?
|
Protein Processing, Post-Translational | 1 | 2008 | 78 |
Why?
|
Vasoconstriction | 1 | 2007 | 37 |
Why?
|
Mutation | 2 | 2002 | 340 |
Why?
|
Mice, Mutant Strains | 1 | 2007 | 77 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2007 | 18 |
Why?
|
Fibroblasts | 1 | 2011 | 179 |
Why?
|
Membrane Potentials | 1 | 2008 | 99 |
Why?
|
Extracellular Matrix | 1 | 2008 | 79 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2007 | 45 |
Why?
|
Mice, Inbred C3H | 1 | 2007 | 86 |
Why?
|
Action Potentials | 1 | 2008 | 77 |
Why?
|
Pneumococcal Infections | 1 | 2007 | 31 |
Why?
|
Myoblasts | 1 | 2006 | 17 |
Why?
|
Carbon Monoxide | 1 | 2006 | 24 |
Why?
|
Diabetes Mellitus | 1 | 2008 | 72 |
Why?
|
Smad3 Protein | 1 | 2007 | 26 |
Why?
|
Survival Rate | 1 | 2009 | 250 |
Why?
|
Species Specificity | 1 | 2007 | 186 |
Why?
|
Myocardial Reperfusion | 1 | 2006 | 17 |
Why?
|
Muscle Cells | 1 | 2006 | 9 |
Why?
|
Calcium-Transporting ATPases | 1 | 2006 | 17 |
Why?
|
Deoxyguanosine | 1 | 2005 | 7 |
Why?
|
Cell Culture Techniques | 1 | 2006 | 74 |
Why?
|
Sarcoplasmic Reticulum | 1 | 2006 | 21 |
Why?
|
Cardiomyopathies | 1 | 2006 | 43 |
Why?
|
Myocardial Contraction | 1 | 2006 | 52 |
Why?
|
Ventricular Remodeling | 1 | 2006 | 21 |
Why?
|
bcl-2-Associated X Protein | 1 | 2005 | 40 |
Why?
|
Receptors, Adrenergic, beta | 1 | 2006 | 35 |
Why?
|
Sperm Tail | 1 | 2005 | 2 |
Why?
|
Focal Adhesions | 1 | 2005 | 5 |
Why?
|
Sperm Motility | 1 | 2005 | 9 |
Why?
|
Ligands | 1 | 2006 | 116 |
Why?
|
Subcellular Fractions | 1 | 2005 | 67 |
Why?
|
Ubiquitin | 1 | 2005 | 41 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2005 | 25 |
Why?
|
Chromones | 1 | 2004 | 22 |
Why?
|
Hemodynamics | 1 | 2006 | 131 |
Why?
|
Morpholines | 1 | 2004 | 28 |
Why?
|
Epithelial Cells | 1 | 2007 | 135 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2005 | 71 |
Why?
|
Down-Regulation | 1 | 2006 | 150 |
Why?
|
Cytoskeleton | 1 | 2005 | 47 |
Why?
|
Genetic Variation | 1 | 2005 | 91 |
Why?
|
Nuclear Localization Signals | 1 | 2004 | 16 |
Why?
|
Cell Differentiation | 1 | 2010 | 262 |
Why?
|
Ventricular Function | 1 | 2004 | 23 |
Why?
|
bcl-Associated Death Protein | 1 | 2003 | 5 |
Why?
|
Oligonucleotides, Antisense | 1 | 2004 | 46 |
Why?
|
14-3-3 Proteins | 1 | 2003 | 9 |
Why?
|
Culture Media, Serum-Free | 1 | 2003 | 32 |
Why?
|
Thiazolidinediones | 1 | 2004 | 35 |
Why?
|
Immediate-Early Proteins | 1 | 2004 | 18 |
Why?
|
Long QT Syndrome | 1 | 2008 | 35 |
Why?
|
Sequence Deletion | 1 | 2004 | 88 |
Why?
|
Cycloheximide | 1 | 2003 | 51 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 243 |
Why?
|
Two-Hybrid System Techniques | 1 | 2004 | 42 |
Why?
|
Umbilical Cord | 1 | 2003 | 18 |
Why?
|
Receptor, Angiotensin, Type 1 | 1 | 2003 | 7 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2004 | 55 |
Why?
|
Mass Spectrometry | 1 | 2003 | 57 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2004 | 67 |
Why?
|
Multigene Family | 1 | 2003 | 52 |
Why?
|
Heterotrimeric GTP-Binding Proteins | 1 | 2003 | 14 |
Why?
|
COS Cells | 1 | 2003 | 73 |
Why?
|
Oligonucleotides | 1 | 2003 | 35 |
Why?
|
Focal Adhesion Kinase 2 | 1 | 2002 | 7 |
Why?
|
Cytochalasin D | 1 | 2002 | 16 |
Why?
|
Proto-Oncogene Proteins c-cbl | 1 | 2002 | 7 |
Why?
|
DNA Mutational Analysis | 1 | 2003 | 110 |
Why?
|
Mutagenesis | 1 | 2004 | 74 |
Why?
|
Genes, Dominant | 1 | 2003 | 68 |
Why?
|
Models, Genetic | 1 | 2003 | 90 |
Why?
|
DNA, Complementary | 1 | 2004 | 139 |
Why?
|
Tropoelastin | 1 | 2002 | 4 |
Why?
|
Gelsolin | 1 | 2002 | 9 |
Why?
|
Muscle, Smooth | 1 | 2003 | 69 |
Why?
|
SH2 Domain-Containing Protein Tyrosine Phosphatases | 1 | 2002 | 5 |
Why?
|
E-Selectin | 1 | 2002 | 12 |
Why?
|
ets-Domain Protein Elk-1 | 1 | 2002 | 9 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2004 | 41 |
Why?
|
Acetylcysteine | 1 | 2002 | 42 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2003 | 126 |
Why?
|
Gene Library | 1 | 2002 | 50 |
Why?
|
Flavonoids | 1 | 2003 | 46 |
Why?
|
Catalytic Domain | 1 | 2002 | 27 |
Why?
|
Mitochondria | 1 | 2006 | 100 |
Why?
|
Globins | 1 | 2002 | 21 |
Why?
|
Mitogen-Activated Protein Kinase 8 | 1 | 2001 | 4 |
Why?
|
Drug Synergism | 1 | 2002 | 104 |
Why?
|
Substrate Specificity | 1 | 2002 | 90 |
Why?
|
Organ Specificity | 1 | 2002 | 104 |
Why?
|
Cell Adhesion Molecules | 1 | 2002 | 48 |
Why?
|
Immunohistochemistry | 1 | 2006 | 355 |
Why?
|
Drug Resistance | 1 | 2002 | 83 |
Why?
|
Cytoskeletal Proteins | 1 | 2002 | 55 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2001 | 12 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2002 | 28 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2001 | 16 |
Why?
|
Guinea Pigs | 1 | 2001 | 76 |
Why?
|
Blotting, Northern | 1 | 2002 | 151 |
Why?
|
Perfusion | 1 | 2001 | 73 |
Why?
|
Peptides | 1 | 2003 | 154 |
Why?
|
ras Proteins | 1 | 2001 | 16 |
Why?
|
Myogenic Regulatory Factors | 1 | 2001 | 9 |
Why?
|
Umbilical Veins | 1 | 2001 | 46 |
Why?
|
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt | 1 | 2000 | 3 |
Why?
|
Peptidylprolyl Isomerase | 1 | 2000 | 4 |
Why?
|
Onium Compounds | 1 | 2000 | 9 |
Why?
|
NADH, NADPH Oxidoreductases | 1 | 2000 | 14 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2002 | 51 |
Why?
|
GTP-Binding Proteins | 1 | 2002 | 47 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2001 | 16 |
Why?
|
Aminoquinolines | 1 | 2000 | 15 |
Why?
|
PC12 Cells | 1 | 2001 | 27 |
Why?
|
Carotid Artery Injuries | 1 | 2000 | 17 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2001 | 22 |
Why?
|
Glutamic Acid | 1 | 2001 | 66 |
Why?
|
Genes, Reporter | 1 | 2001 | 111 |
Why?
|
Vascular Diseases | 1 | 2000 | 60 |
Why?
|
Interleukin-1 | 1 | 2001 | 109 |
Why?
|
Polymerase Chain Reaction | 1 | 2002 | 279 |
Why?
|
Carrier Proteins | 1 | 2003 | 177 |
Why?
|
Cerebral Cortex | 1 | 2001 | 108 |
Why?
|
Female | 1 | 2010 | 1643 |
Why?
|
